New Findings to Describe the Decrease of Influenza A/B In 2021

Main Article Content

Homagk L Hornung L

Abstract

The end of the 2019/2020 influenza season was already registered in early summer 2020, and in the following season. There was an nearly complete absence of influenza. So far, the sometimes strict Covid-19 containment measures with contact restrictions and the obligation to wear a mask have been mentioned as reasons. The further processing of this influenza gap showed multifactorial reasons also the lack of registration of influenza cases This retrospective cohort study looks for further reaseons and from several perspectives in order to develop strategies for a representative recording of influenza cases derive.


For Evaluation the data of the German center of Disease Control (RKI) by the GrippeWeb, the RKI’s Survstat® tool and the RKI’s reporting data on the new coronavirus were used. In addition, an evaluation of billing data from the EBM (Uniform Value Scale) from 2017 to 2022 for the GOP (fee schedule item) 32006 and 32841 as well as an evaluation of data on sick leave and illness statistics from 2019 to 2021 and the consideration of inpatient and outpatient health costs based on the data requested in writing from the Federal Ministry of Health was performed.


In contrast to influenza A/B, the other viral respiratory pathogens (adenovirus, parainfluenza virus and RS virus) do not show any significant reduction. From 2020, the number of reports of respiratory infections to the RKI increased from an average of 300,000 annual reports by 2019 to 1,985,985 reports in 2020, over 5,453,017 reports in 2021 and to 29,681,158 in 2022. On the other hand cases of incapacity to work due to respiratory infections fell from 31.0% in 2019 to 15.3% in 2021. Influenza-specific diagnoses (ICD: J10.1-3) were encrypted 33,727 times in 2021, in 2020 there were still 109,846. In the outpatient sector in particular, the treatment costs are falling from 2019 to 2021.


The reduction in influenza A and B from 2020 as a result of the comprehensive Covid-19 control measures, including the obligation to wear masks, cannot be considered a major reason; rather, the aspect of underreporting of influenza cases plays a significant role. Therefore, the reporting quantity of the sentinal practices should be considered and the recording of incapacity diagnoses should be taken into account.

Keywords: Influenza, RKI, GrippeWeb, Covid-19

Article Details

How to Cite
L, Homagk; L, Hornung. New Findings to Describe the Decrease of Influenza A/B In 2021. Medical Research Archives, [S.l.], v. 12, n. 2, july 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/4123>. Date accessed: 22 dec. 2024. doi: https://doi.org/10.18103/mra.v11i7.1.4123.
Section
Research Articles

References

1 WHO Influenza (Seasonal). https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) . Accessed: January 14, 2023.
2 Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358(9291):1410–1416.
3 de Fougerolles TR, Puig-Barbera J, Kassianos G. et al. A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom. Influenza Other Respi Viruses. 2022;16:417–428.
4 Arbeitsgemeinschaft Influenza. Bericht zur Epidemiologie der Influenza in Deutschland Saison 2017/18: 7-9.
5 Buchholz U, Buda S and Prahm K: Abrupter Rückgang der Raten an Atemwegserkrankungen in der deutschen Bevölkerung. Epidemiologisches Bulletin 16:2020, 7–9.
6 Dzien A et al. Will the COVID-19 pandemic slow down in the northern hemisphere by the onset of summer? An epidemiological hypothesis. Infection. 2020;48: 627–629.
7 Adlhoch C et al. Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021. Eurosurveillance. 2021; 26:210-221.
8 Heinzinger S et al. Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany). Epidemiology and Infection. 2021;149,e226,1–7.
9 Stamm P, Sagoschen I, Weise K, Plachter B, Münzel T, Gori T, Vosseler M. Influenza and RSV incidence during COVID 19 pandemic—an observational study from in hospital point of care testing. Medical Microbiology and Immunology. 2021;210:277–282. https://doi.org/10.1007/s00430-021-00720-7
10 Karg MV, Alber B, Kuhn C, Bohlinger K, Englbrecht M, Dormann H. SARS-CoV-2, Influenza und Norovirus - Die Klinikperspektive im Vergleich. MedKlin IntensivmedNotfmed. 2022;117:209–217.https://doi.org/10.1007/s00063-021-00783-7
11 Wu D, Liu Q, Wu T, Wang D, Lu J. The impact of COVID-19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou, China. Immun Inflamm Dis. 2020;8(4):844–846.
12 de Miguel Buckley R, Trigo E, de la Calle-Prieto F, Arsuaga M, Diaz-Menendez M. Social distancing to combat COVID-19 led to a marked decrease in food-borne infections and sexually transmitted diseases in Spain. J Travel Med. 2020;27(8). 134-141.
13 Steffen R, Lautenschlager S, Fehr J. Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland. J Travel Med. 2020;27(8):taaa180
14 https://www.rki.de/DE/Content/Infekt/Sentinel/Grippeweb/grippeweb_node.html, Accessed: January 14, 2023

15 https://survstat.rki.de/Content/Query/Create.aspx, Accessed: January 26, 2023

16 Arbeitsunfähigkeit: Fälle und Tage nach Diagnosen 2020. Ergebnisse der Krankheitsartenstatistik der gesetzlichen Krankenversicherung. www.bundesgesundheitsministerium.de. S 1-48, Accessed: January 14, 2023
17 Arbeitsunfähigkeit: Fälle und Tage nach Diagnosen 2019. Ergebnisse der Krankheitsartenstatistik der gesetzlichen Krankenversicherung. www.bundesgesundheitsministerium.de. S 1-52, Accessed: January 14, 2023
18 Meyer M., Wing L., Schenkel A. Krankheitsbedingte Fehlzeiten in der deutschen Wirtschaft im Jahr 2021. Springer-Verlag GmbH, B. Badura et al. (Hrsg.), Fehlzeiten-Report 2022, Fehlzeiten-Report. 2022:327ff. https://doi.org/10.1007/978-3-662-65598-6_19
19 Grobe TG., Braun A. BARMER Gesundheitsreport 2022 Schriftenreihe zur Gesundheitsanalyse – Band 34. aQua – Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH. 2023: 44-59.
20 Grobe TG., Bessel S. Gesundheitsreport 2022 – Arbeitsunfähigkeiten, Herausgeber: Techniker Krankenkasse. aQua – Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH. 2023: 21-34.
21 https://www.icd-code.de , Accessed:
January 26, 2023
22 Fricke LM, Glockner S, Dreier M, Lange B. Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review. J Infect 2021; 82 (1):1–35.
23 Eigner. U, Verstraeten T, Weil J. Decrease in norovirus infections in Germany following COVID-19 containment measures. Letters to the Editor / Journal of Infection 82 (2021) 276–316
24 Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. Laboratory efforts to cultivate noroviruses. J Gen Virol 2004; 85: 79-87.
25 Zhu N, Zhang D, Wang W. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. Engl J Med. 2020. 20;382(8):727-733.
doi: 10.1056/NEJMoa2001017.
26 Lamb RA, Choppin PW. The gene structure and replication of influenza virus. In: Annual Review of Biochemistry. 1983. 52; 467–506.
27 Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 2020;368 (6493):860–8.
28 https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Adenovirus_Konjunktivitis.html, Accessed: January 14, 2023
29 Burchard GD, Kaufmann SHE, Schulz TF. Medizinische Mikrobiologie und Infektiologie. herausgegeben von Sebastian Suerbaum, Springerverlag, Kap. 60, S. 489
30 https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Influenza_saisonal.html , Accessed: January 14, 2023
31 Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews 2020. 11. Art. No.: CD006207. DOI: 10.1002/14651858.CD006207.pub5.